Latest News

Expanesthetics Considers Office in Melbourne, Australia in Preparation for Clinical Trial Phase

August 12, 2016

This month, Expanesthetics' CEO, Mark Holman, and COO, Shane Austin, traveled to Melbourne, Australia to explore clinical resources and strengthen the company's network of relationships; all this to lay the groundwork for future first-in-human (FIH) clinical trials. Melbourne is a global hub of pharmaceutical clinical trials, and as the company's anesthetic and analgesic programs continue to advance, Expanesthetics is contemplating the launch of an "Asian-Pacific" office in Australia to take advantage of the vast network of resources that collaborators in that country have to offer, as well as the advantageous regulatory environment "down under." Productive meetings with Murdoch Children's Research Institute, the State Government of Victoria - Department of Economic Development and many others have given Expanesthetics many reasons to look favorably on Melbourne as the future site of such an expansion. Stay tuned for updates!

Back to top

Expanesthetics Hires Chief Scientific Officer, Dr. Peter Wright

July 1, 2016

Expanesthetics continues to expand its management team with the hiring this month of part-time Chief Scientific Officer Dr. Peter Wright. Dr. Wright has a PhD in Pharmacokinetics, is a former Professor of Anesthesia at the University of California, San Francisco and has been practicing anesthesia for over 25 years. He will be leading Expanesthetics' research efforts as both the anesthetic and analgesic programs continue to advance through preclinical studies. Please join us in welcoming Dr. Wright to the Expanesthetics family!

Back to top

Expanesthetics Crosses $1M Funding Milestone

February 7, 2016 | Davis Enterprise

The Davis Enterprise, Expanesthetics' home town newspaper, reported the achievement of an important fundraising milestone. In 2012, Mark Holman met Robert Brosnan at an entrepreneurship academy at the local university campus. Robert had come to learn about building new companies on a foundation of innovative technology and Mark was serving as a mentor to the many faculty members and students.

Back to top

Expanesthetics Spotlighted by Leading Research University

February 2, 2016 | Child Family Institute for Innovation and Entrepreneurship

Founded in 2012, Expanesthetics is tackling one of the longest-standing scientific questions in modern medicine: How do general anesthetics work? The company's goal is to expand the choice of anesthetic agents available for clinical use in order to improve patient outcomes and reduce costs. This story tells some of Expanesthetics' history and progress to-date.

Back to top

Expanesthetics Sponsors 54th Clinical Conference in Pediatric Anesthesiology

February 1, 2016

Expanesthetics returns this month to sponsor and exhibit at the 54th Clinical Conference in Pediatric Anesthesiology in Anaheim, California. Because inhalation anesthesia plays a particularly important role in the pediatric setting, Expanesthetics is actively seeking to develop a new and improved inhalation general anesthetic to address the unique challenges in pediatric anesthesia. Expanesthetics' CEO, Mark Holman, feels that the feedback received from pediatric clinicians at this event make it a very important piece of the company’s strategy to serve all segments of the anesthesia community.

Back to top